The selected cell lines include A549, a lung cancer cell line that is characterized by its high expression of EGFR; SKOV-3, an ovarian cancer cell line, selected for its overexpression of both EGFR and HER2; and the breast cancer cell line (SKBR-3), characterized by HER2 overexpression. Here, ERBB2 is linked to ovarian cancer.